DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/m9t3ql/cartilage) has announced the addition of the "Cartilage Degeneration - Pipeline Review, H2 2013" report to their offering.
'Cartilage Degeneration - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Cartilage Degeneration, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cartilage Degeneration.
- A snapshot of the global therapeutic scenario for Cartilage Degeneration.
- A review of the Cartilage Degeneration products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Cartilage Degeneration pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.
Key Topics Covered:
Cartilage Degeneration Overview
Clinical Stage Products
Early Stage Products
Cartilage Degeneration - Products under Development by Companies
Cartilage Degeneration - Companies Involved in Therapeutics Development
Cartilage Degeneration - Therapeutics Assessment
sprifermin - Drug Profile
Chondrogen - Drug Profile
MSB-CAR-001 - Drug Profile
AOD-9604 - Drug Profile
THR-166 - Drug Profile
ST-03 - Drug Profile
Cartilage Degeneration - Recent Pipeline Updates
List of Tables
List of Figures
For more information visit http://www.researchandmarkets.com/research/m9t3ql/cartilage
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.